Sexually Dimorphic Role of Toll-like Receptor 4 (TLR4) in High Molecular Weight Hyaluronan (HMWH)-induced Anti-hyperalgesia
Autor: | Dionéia Araldi, Ivan José Magayewski Bonet, Jon D. Levine, Paul G. Green |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
high molecular weight hyaluronan toll-like receptor 4 Medical and Health Sciences 0302 clinical medicine 030202 anesthesiology Immunologic Anesthesiology Prostaglandin E2 Hyaluronic Acid Receptor Sex Characteristics Pain Research anti-hyperalgesia Neurology Hyperalgesia Second messenger system Ovariectomized rat lipids (amino acids peptides and proteins) Female medicine.symptom medicine.drug Signal Transduction medicine.medical_specialty Ovariectomy Inflammation Article Dinoprostone prostaglandin E(2) (PGE(2)) hyaluronan 03 medical and health sciences Adjuvants Immunologic Internal medicine medicine Animals Adjuvants prostaglandin E-2 (PGE(2)) business.industry Animal Psychology and Cognitive Sciences Estrogen Rats Toll-Like Receptor 4 Molecular Weight Disease Models Animal Anesthesiology and Pain Medicine Endocrinology Disease Models Myeloid Differentiation Factor 88 TLR4 Neurology (clinical) business 030217 neurology & neurosurgery |
Zdroj: | The journal of pain, vol 22, iss 10 J Pain |
Popis: | High molecular weight hyaluronan (HMWH), a prominent component of the extracellular matrix binds to and signals via multiple receptors, including cluster of differentiation 44 (CD44) and toll-like receptor 4 (TLR4). We tested the hypothesis that, in the setting of inflammation, HMWH acts at TLR4 to attenuate hyperalgesia. We found that the attenuation of prostaglandin E2 (PGE2)-induced hyperalgesia by HMWH was attenuated by a TLR4 antagonist (NBP2-26245), but only in male and ovariectomized female rats. In this study we sought to evaluated the role of the TLR4 signaling pathway in anti-hyperalgesia induced by HMWH in male rats. Decreasing expression of TLR4 in nociceptors, by intrathecal administration of an oligodeoxynucleotide (ODN) antisense to TLR4 mRNA, also attenuated HMWH-induced anti-hyperalgesia, in male and ovariectomized female rats. Estrogen replacement in ovariectomized females reconstituted the gonad-intact phenotype. The administration of an inhibitor of myeloid differentiation factor 88 (MyD88), a TLR4 second messenger, attenuated HMWH-induced anti-hyperalgesia, while an inhibitor of the MyD88-independent TLR4 signaling pathway did not. Since it has previously been shown that HMWH-induced anti-hyperalgesia is also mediated, in part by CD44 we evaluated the effect of the combination of ODN antisense to TLR4 and CD44 mRNA. This treatment completely reversed HMWH-induced anti-hyperalgesia in male rats. Our results demonstrate a sex hormone-dependent, sexually dimorphic involvement of TLR4 in HMWH-induced anti-hyperalgesia, that is MyD88 dependent. PERSPECTIVE: The role of TLR4 in anti-hyperalgesia induced by HMWH is a sexually dimorphic, TLR4 dependent inhibition of inflammatory hyperalgesia that provides a novel molecular target for the treatment of inflammatory pain. |
Databáze: | OpenAIRE |
Externí odkaz: |